nih grants awarded 2022
1 min readNIA supports the following research grant mechanisms including Program Project Grants, Center Grants, and Cooperative Agreements to support multidisciplinary teams of researchers: Research Projects. All - new, renewal, resubmission, revisions. renewal, resubmission, revision, Individual National Research Service Awards (Standard), R43, R44, U43, U44, Search for jobs, including scientific, administrative and executive careers at NIMH. All - new, renewal, resubmission, revision, G07, G08, G11, G12, G13, G20, R24, S06, S11, S21, S22, SC1, SC2, SC3, UG1, U10, U19, U24, U2C, U41, U42, U45, U54, U56 Guide for Grants and Contracts, 2022-2023 NIH Grants Conference& PreCon Events Season: Session Recordings & Resources, U.S. Department of Health and Human Services, Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding, Applicant/Recipient COVID-19 Update History, Get the latest research information from NIH, How to Apply Video Find the latest NIH and NIMH policies, guidance, and resources for clinical research. Hours: 8:30 a.m. 5 p.m. UCSF continued to rank highly among all public and private institutions nationwide, ranking fourth overall. Learn about funding opportunities for small businesses. See more articles in this edition. Information about resources such as data, tissue, model organisms and imaging resources to support the NIMH research community. The R01 is the NIH standard independent research project grant. Stilil need assistance? Data frozen as of 10/03/2022. Through another collaborative BRAIN grant, Dr. Zhuang aims to develop a transformative multimodal experimental platform to uncover the brain-wide architecture of neuronal circuits underlying parenting behavior in molecular, functional, connectivity-based and computational terms. Dr. Gradinaru's research focuses on developing new neuromodulation methods that allow neuronal activity readout and control tools that are minimally invasive for early intervention and treatment of brain disorders. Grants & Funding Funding Opportunities Funding Opportunities & Related Notices The table below lists all active NIDCR funding opportunities and notices. Email: nimhinfo@nih.gov Learn more about NIMH research areas, policies, resources, and initiatives. Learn more about the NIH Guide and subscribe to receive updates today! Notice of Information: Anticipated Publication of the PHS 2023-2 Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications Request for Information (RFI): Research Opportunities to End Hunger, Food and Nutrition Insecurity. ALL-ACCESS. Date Range Release Date Advanced Search Internal Service Error. By UCSF News on July 05, 2022 For the 15th year in a row, UC San Francisco garnered the top spot among public institutions in funding from the National Institutes of Health (NIH) in 2021. Responses to all questions are required. The bill will also establish the Biden Administration's signature . For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: . Clinical Trial Not Allowed (UG3/UH3), Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Notice of Correction to NOT-OD-22-109 - Inviting Comments and Suggestions on the Development of a Prize Competition for Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility. Program Project Grants and Center Grants P01 Find the names, telephone numbers, email addresses, and office locations of NIMH staff. Elizabeth Hillman Ph.D., is a Professor of Biomedical Engineering and Radiology andthe Herbert and Florence Irving Professor at the Zuckerman Institute. 2-Day Conference Agendawith Session Descriptors(PDF). Use these free digital, outreach materials in your community and on social media to spread the word about mental health. Workplace, NIH Regional Seminars on Program Funding. Department of Health and Human ServicesUSA.gov. NOTE: Applicants should check with the relevant Institute or Center (IC), since some do not accept P series applications for all three receipt/review/award cycles. August 2022 NIH BRAIN Initiative Neuroethics and Multi-Council Working Group meetings. Our amount of total research funding is ever fluctuating. Explore the NIMH grant application process, including how to write your grant, how to submit your grant, and how the review process works. Explore year-by-year NIH funding by institution, state, congressional district, and more! Laboratory Animal Welfare Workshops & Conferences, SEED Events (for the innovator High-End Instrumentation Grant Program - The HEI Program funds grant awards in the $600,001 to $2,000,000 range. Notice of Funding Opportunity (NOFO) Number . DP2 NIH Director's New Innovator Awards Announcement Type Reissue of RFA-RM-21-016 Related Notices None Funding Opportunity Announcement (FOA) Number RFA-RM-22-019 Companion Funding Opportunity None Number of Applications Xiaowei Zhuang, Ph.D., is a Howard Hughes Medical Institute Investigator, and the David B. Arnold, Jr. Upcoming Grant Deadlines June 28, 2023 Public Impact Projects at Smaller Organizations Division of Public Programs July 14, 2023 Fellowships Open Book Program Office of Digital Humanities July 18, 2023 Humanities Collections and Reference Resources Division of Preservation and Access Examples of Projects Funded by NEH New NIH Grant Funding in 2022 Anticipated New NIH Awards, Scored Well * This amount represents all active sponsored projects in our department as of October 17, 2022 where one of our faculty members is either PD/PI, MPI, or clinical trial lead. The Fogarty Emerging Global Leader Award aims to provide research support and protected time to a research scientist from a LMIC who holds an academic junior faculty position or research scientist appointment at an LMIC academic or research institution. Dr. Hillmans research focuses on developing a wide range of multi-scale in-vivo imaging methods including Swept Confocally Aligned Planar Excitation Microscopy(SCAPE) microscopy for high-speed 3D imaging of neural activity and Human brain Optimized Light-Sheet (HOLiS) microscopy. C06/UC6 NIMH hosts an annual lecture series dedicated to innovation, invention, and scientific discovery. Sept 5, 2015 - N/A for SBIR/STTR Applications using Standard Due Dates. The study found that men had a 2-3 times greater rate of overdose mortality from opioids (like fentanyl and heroin) and psychostimulants (like methamphetamine and cocaine). In December, NIH published a revised Grants Policy Statement (GPS) for fiscal year 2022. Data released on 1/13/2022. Laboratory Animal Welfare Workshops & Conferences, SEED Events (for the innovator (COVID-19), Family-Friendly These four awards include: NIH issued eight Pioneer awards, 72 New Innovator awards, nine Transformative Research awards, and 14 Early Independence awards for 2022. Fiscal Year : 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 For example, NIH added language to coincide with NIH policy on enhancing diversity in NIH-supported conferences. In FY2022, NIH spent $33.3 billion of its total $45.2 billion appropriation for competing and noncompeting grant awards. We publish daily and issue a table of contents weekly. Explore this new interactive infographic to get to know the different programs by career stage, learn useful tips, and better understand the lingo of NIH funding. February 02, 2022 NIMH supports research at universities, medical centers, and other institutions via grants, contracts, and cooperative agreements. Tutorials, Post Award Monitoring and NIMH Priorities on Research Using Genetically Modified Nonhuman Primates. The NIMH Strategic Plan for Research is a broad roadmap for the Institutes research priorities over the next five years. Read the table carefully. Outreach (DCO), Small Business Education and Entrepreneurial More information is available at the Common Fund website: https://commonfund.nih.gov. NIMH offers expert-reviewed information on mental disorders and a range of topics. The BRAIN-funded researchers Drs. The NIH Final Policy for Data Management and Sharing is in Effect: Planning for Success! Clinical Trial Not Allowed (UG3/UH3), HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Basic Experimental Studies with Humans Required), HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed), HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required), HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed), Notice of Participation of NIMH in NOT-DA-23-008,"Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes", Notice of Early Expiration of "Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation", NOT-AI-22-056, Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees, Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional), Maternal Health Research Centers of Excellence Data Innovation and Coordinating Hub/Resource Center (U24 Clinical Trial Not Allowed), Maternal Health Research Centers of Excellence Implementation Science Hub/Resource Center (U24 Clinical Trial Optional), Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People, Review of the Accuracy of Grants Information for Fiscal Year 2022, Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional), HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional), HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional), Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech, Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence, Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional), Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional), HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional), NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional), Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional), PATC3H Implementation Science Network (PATC3H-IN) Coordination, Translation and Advanced Methods and Analytics Center (UM2 Clinical Trial Optional), Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Clinical Research Centers (UG1 Clinical Trial Optional), Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required), Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed), NIH Request for Information (RFI) on Acquiring Electronic Health Record Data from Health Information Networks and Health Information Exchanges for the All of Us Research Program, HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required), HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required), Notice Announcing NIH All of Us Research Program Engagement, Communications, and Enrollment Partners Other Transactions (OT) Research Opportunity Announcement (ROA), Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening, Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan, Register Today for the NIH Data Management and Sharing (DMS) Policy Webinar Series, HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional), Notice of Change to Language for the Eligible Individual Criteria for PA-21-052: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity), Notice of Participation and Areas of Interest of NIMH in RFA-HL-23-015 and RFA-HL-23-016 "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI) (UG3/UH3) (U24)", Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed), Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed), HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required), Notice of Information on High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls and Young Women (Ages 12-24), Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes, Notice of Information: High Priority Countries for the Center for Global Mental Health Research, Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. The omnibus will provide a total of $45 billion for NIH in FY 2022, an increase of $2.03 billion, or 4.7 percent, over the FY 2021 enacted level. We are privileged to support this innovative science.. Before submitting your comment, please review our blog comment policies. The US National Institutes of Health (NIH) supports medical research in non-government universities and hospitals and some small businesses. 2022 : FOA Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) FOA Number: RFA-NS-20-011 Our Help page will direct you to the appropriate contact. See, National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892. Learn about obligations of your grant award. This browser is not supported - Some features might not work. Learn more about the functions of each NIMH office and division. Questions related to a specific opportunity should be directed to the IC contact listed in Section VII of the funding opportunity. Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed), Emerging Global Leader Award (K43 Independent Clinical Trial Required), Request for Information (RFI) on User Experience with Scientific Data Sources and Tools, Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed), Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed), The BRAIN Initiative Plan for Enhancing Diverse Perspectives (PEDP), Notice of Intent to Publish a Funding Opportunity Announcement: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional), Notice of Special Interest to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed), Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2022 Council, RESCINDED - Clarification and Guidance for Applicants Preparing Applications for the Fall 2021 Due Dates During the COVID-19 Pandemic, Reminder of Guidance on Requirement for NIH Single Institutional Review Board (IRB) Plan, Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional), Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional), Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations, Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed), Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH)), Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required), Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed), Request for Information (RFI): Systematic Review Centers with Nutrition Expertise for DRI Development, Notice of Extension to PA-18-907, "New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)". Try using a different browser such as Chrome, Edge, Firefox, or Safari. Funding News Edition: NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. U.S. Department of Health & Human Services, Behavioral Codes of Conduct for NIH Award Recipients, Keeping Track of the Latest NIH Policy Changes, Revised NIH Grants Policy Statement for FY 2021. All - new, renewal, resubmission, revision, R03, R21, R33, R21/R33, R34, R36, U34, UH2, UH3, UH2/UH3 Find Funding NIH Guide for Grants and Contracts. Public domain. The 2022 class of fellows will beinducted at the NAI 12th Annual Meeting on June 27th, 2023, in Washington, D.C. This browser is not supported - Some features might not work. Research Conducted at NIMH (Intramural Research Program), Research Training and Career Development Opportunities, Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed), Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-MH-23-330 and RFA-MH-23-331 K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity, Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed), Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional), Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional), Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed), HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed), Notice of Technical Assistance Webinar for RFA-MH-24-120, "Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)", Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed), Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-300 Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed), Notice of Special Interest (NOSI): HIV Cure-Related Research in Diverse Populations, Notice of Special Interest (NOSI): Administrative Supplement Program to Help Develop Alzheimers-Focused NIH Grants, Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional), BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed), Notice of Special Interest (NOSI): Clinical Studies of CNS Complications in People with HIV, Notice of Special Interest (NOSI): Eradication of HIV-1 from Central Nervous System Reservoirs, Notice of Special Interest (NOSI): Neuropathogenesis of CNS Complications Associated with HIV, Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional), Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional), NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed), Request for Information on Catalyzing the Development and Use of Novel Alternative Methods to Advance Biomedical Research, Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed), Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets, Guidance on Flexibilities for Conducting Semiannual Program Review, Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional), Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research, Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional), Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment, Notice of Change to RFA-OD-23-050: Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed), Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed), Notice of Special Interest (NOSI): Intersectional Stigma and Discrimination (ISD), or Other Social and Structural Determinants of Health (SSDOH) in HIV Prevention and Treatment, Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults, Notice of Information: Anticipated Publication of the PHS 2023-2 Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications, Notice of Correction to Due Date for Letter of Intent for RFA-MH-23-265 "Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed)", Notice of the Extension of the Expiration Date for NOT-OD-23-040: Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21), Notice of Intent to Publish a Funding Opportunity Announcement for Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed), HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional), Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional), Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional), Notice of Special Interest (NOSI): Administrative Supplements to Enhance Institutional Data Science Capacity, Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II or Phase IIB Awardees, BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional), Notice to Extend the Expiration Date for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed), Notice of Change to Funds Available and Anticipated Number of Awards for RFA-MH-23-106 "Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)", Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees, Notice of Special Interest (NOSI): Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease, Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed), Emergency Award: RADx-UP Dissemination and Implementation (D and I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional), "Notice of Intent to Publish a Funding Opportunity Announcement for NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)", Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-260 "Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)", Notice of Special Interest (NOSI): NIMH Planning Grants for Natural History Studies of Rare Genetic Neurodevelopmental Disorders, Notice of Special Interest (NOSI): Pre-Clinical Research on Gene Therapies for Rare Genetic Neurodevelopmental Disorders, BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed), BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed), Notice of Correction to Due Dates for Letters of Intent for PAR-23-060 "Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)", Notice of Correction to Due Dates for Letters of Intent for PAR-23-061 "Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional), Notice of Correction to Due Dates for Letters of Intent for PAR-23-062 "Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional), BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional), Request for Information (RFI) on Clarification of Animal Activities Exempt from the PHS Policy Requirements for IACUC Review, NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed), Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed), Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required), STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed), Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed), Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed), BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed), BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed), BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required), Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional), Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed), BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed), Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional), Notice of Change of the Locus of Review, Application Types Allowed and Expiration date for PAR-23-097, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)", Notice of Change of the Locus of Review for PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)", Request for Information (RFI): Food is Medicine Research Opportunities, Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed), Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed), Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional), BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required), NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed), BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32), BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional), Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed), Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional), Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional), Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional), Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional), Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed), Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed), Notice of Intent to Publish a Funding Opportunity Announcement for Early-stage Data Repositories and Knowledgebases (Clinical Trials Not Allowed), Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) Mechanism (U01 Clinical Trial Optional), Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed), Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional), Notice of Intent to Publish a Funding Opportunity Announcement for Biotypes of CNS complications in people living with HIV (P01 Clinical Trial Not Allowed), BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed), BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed), Centers for AIDS Research (P30 Clinical Trial Not Allowed), Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed), NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed), NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed), NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed), Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional), NIH Can No Longer Grant Common Rule Exceptions to the Use of a Single IRB for Multi-site Research After the COVID-19 Public Health Emergency Expiration Date of May 11, 2023, Notice to Extend the Expiration Date for All NIH Career Development Award (K) Parent Announcements, The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2023 SGM Research Investigator Awards Program, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional), Notice of Intent to Publish a Funding Opportunity Announcement for Established Data Repositories and Knowledgebases (Clinical Trials Not Allowed), Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional), Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed), Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional), Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional), Notice of NIMH Withdrawal from Participation in PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)", Notice of Clarification Regarding Eligibility Information for SBIR/STTR Commercialization Readiness Pilot Program (CRP), Notice of Participation of NIMH in PAR-20-315, "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)", Request for Information on the NIH Plan to Enhance Public Access to the Results of NIH-Supported Research, Notice of Change in Award Budget for RFA-MH-22-271, "Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)", Notice of Change to Award Budget for SBIR/STTR Commercialization Readiness Pilot Program (CRP), Request for Information (RFI): Re-envisioning U.S. Postdoctoral Research Training and Career Progression within the Biomedical Research Enterprise, NIH Encourages the Use of the ARRIVE Essential 10 Checklist in all Publications Reporting on the Results of Vertebrate Animal and Cephalopod Research, Clinical Trials Results Information Submission: Good Cause Extension Request Process and Criteria Document Posted on ClinicalTrials.gov, Notice of Early Expiration of NINDS BRAIN Initiative Funding Opportunity Announcements (FOA) RFA-NS-21-026 and RFA-NS-21-027, Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed), Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed), Notice of Participation of NIMH in PAR-21-169, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)", Notice of Participation of NIMH in PAR-21-173, "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed), Notice of Participation of NIMH in PAR-22-080, Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed), Request for Information (RFI): Gaps and Opportunities in Global Mental Health Research, Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional), Notice of Intent to Publish a Funding Opportunity Announcement for Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required), Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32), Request for Information (RFI) on Update to NOT-OD-05-034 Guidance on Prompt Reporting of Noncompliances to OLAW, Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-115 and RFA-MH-23-116 "Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 and R21 Clinical Trial Optional)", Notice of Change to RFA-PM-23-002, Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed), Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services, Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ), Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed), Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional), Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional), Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required), Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional), Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required), Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional), Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional), Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional).
Islands Off The Coast Of Australia,
Intro To Judaism Brooklyn,
Breckenridge Hockey Tournament 2023,
River Islands Surf Soccer,
Home Health Aide Salary Per Hour,
Articles N